* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Pulsion Medical Systems SE's PEG Ratio or its related term are showing as below:
LTS:0NFX'
s PEG Ratio Range Over the Past 10 Years
Min: 0.18 Med: 1.71 Max: 12.16
Current: 12.16
During the past 13 years, Pulsion Medical Systems SE's highest PEG Ratio was 12.16. The lowest was 0.18. And the median was 1.71.
LTS:0NFX's PEG Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.98
vs LTS:0NFX: 12.16
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Pulsion Medical Systems SE PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pulsion Medical Systems SE's PEG Ratio
For the Medical Devices subindustry, Pulsion Medical Systems SE's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulsion Medical Systems SE's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Pulsion Medical Systems SE's PEG Ratio falls into.
Pulsion Medical Systems SE PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Pulsion Medical Systems SE (LTS:0NFX) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Pulsion Medical Systems SE PEG Ratio Related Terms
Thank you for viewing the detailed overview of Pulsion Medical Systems SE's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulsion Medical Systems SE (LTS:0NFX) Business Description
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0NFX has been successfully added to your 